IPHARMA has become an academic partner at the SkinHack event which will be held on November, 9-13th in Skolkovo Innovation Centre. The Hackathon applies methods of the machine vision, machine learning and artificial intelligence to analyze images and videos...
In 2016 IPHARMA signed scientific cooperation agreement with the I.M.Sechenov First Moscow State Medical University in which specialists of the company will participate in educational and research projects making educational materials and more. In October...
On November 14-16, XXI Russian Oncology Congress passed in Moscow. It is one of the largest international events in the field of oncology, in which more than 5,000 doctors take part annually. Permanent organizers of the congress: N.N. Blokhin Russian...
On September 14 IPHARMA celebrated the 5th anniversary of the work in the market of clinical trials in the loft on the territory of "Crystal". More than 100 guests, including researchers, partners and customers congratulated IPHARMA. The holiday...
In October, 19th, at 11:00 AM, we will lead the webinar “Clinical trials in oncology introduction”. Register to the webinar What will we discuss at the webinar? Special aspects of clinical trials in oncology What you should pay attention...
In December 2017, IPHARMA received four approvals from the Ministry of health of the Russian Federation to conduct clinical trials. And, according to the results of 2017 (15 approvals), entered the TOP-3 CROs. - BE study of Aberon (abiraterone acetate) ...
14-15 ноября состоится шестая международная конференция Института Адама Смита «Клинические исследования в России» . ИФАРМА является одним из спонсоров конференции. В рамках программы будут обсуждать последние регуляторные изменения, обновление...